Tuesday, 31 March 2020

Global Glioma Diagnosis and Treatment Market 2019 Study and Analysis Research Report Forecast To 2023

Market Scenario
A Glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas. These originate in glial cells surrounding the neurons in the brain.
Global Glioma Diagnosis and Treatment market is expected to grow at a CAGR of approximately 10.1% during the forecast period, 2017–2023.
According to the American Brain Tumor Association, more than 79,000 new cases of primary brain tumors were diagnosed in 2017 with 24.7% of those being gliomas.
Brain tumors are one of the prominent causes of cancer among children and teenagers. Glioma is the most common type of brain tumor which accounts for approximately half of all the astrocytoma. The increasing occurrence of glioblastoma over the years is responsible for the growth of the glioma diagnosis and treatment market. The upcoming drug launches and developments in research are instrumental for the growth of the market. In addition, the current unmet need is expected to drive the gliomas industry over the forecast period. Changing financial demands and access to healthcare facilities are some of the factors that are constraining the market growth.
Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.
The expanding market for the treatment of brain cancer-associated symptoms, the increasing prevalence of brain cancer, and innovations in drug delivery to brain cancer cells are some of the key factors augmenting the demand in the global glioma diagnosis and treatment market. Furthermore, the introduction of novel therapies coupled with various organizations generating awareness and increasing geriatric population are factors driving the growth of the global glioma diagnosis and treatment market.
Key Players
Some of the key players in the global glioma diagnosis and treatment market are Thermo Fisher Scientific Inc. (U.S.), Emcure Pharmaceuticals Ltd. (India), Sigma-Aldrich Co. (U.S.), Pfizer Inc. (U.S.), Taj Pharmaceuticals Limited (India), Novartis International AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), GE Healthcare (U.S.), Siemens Healthineers (U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Merck & Co., Inc. (U.S.), F. Hoffmann-Le Roche AG (Switerland), Arbor Pharmaceuticals, LLC (U.S.), Sun Pharmaceutical Industries, Ltd. (India), Amneal Pharmaceuticals. LLC (U.S.), AstraZeneca (UK), Carestream Health (U.S.), Hitachi Medical Corporation (U.S.), and others.
Segmentation
Geographically, the Americas glioma diagnosis and treatment market is segmented into two major regions, namely, North America and South America.
North America accounted for the largest share of the global gliomas industry in 2016, and the trend is expected to continue over the projected period. Moreover, it is anticipated that about 80,000 new cases will be registered related to brain tumors in the year 2017 which includes 26,000 primary malignant brain tumors.
The Americas glioma diagnosis and treatment market is segmented on the basis of type, diagnosis, treatment, grade, location, and end-user.
Regional Analysis
The global glioma diagnosis and treatment market consist of four major regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.
Growing medical tourism and prevalence of metastatic tumors that require surgical procedures are favoring the growth of the market in the Middle East and Africa. In addition, the development of drug delivery technologies, a combination of modern diagnostic techniques, and increasing awareness of various types of brain tumors are similarly supporting the growth of this market.
The Americas dominates the market owing to the key players domiciled in these regions coupled with the increasing incidences of brain tumor, rising awareness among people, and increasing healthcare expenditure. Brain tumor is the third most common types of cancer in adults in North America. According to the North American Brain Tumor Coalition over 44,500 people in the U.S. were diagnosed with a primary tumor in the brain in 2014. Thus, the increasing incidences of primary brain tumor support the growth of the malignant glioma treatment in North America.  
Asia Pacific is estimated to be the most lucrative market for gliomas due to the increasing occurrence of brain tumors in Asia Pacific countries such as China and others. The growth in the Asian market is fueled by the expanding healthcare infrastructure and presence of untapped market opportunities in this region. This region is considered as an emerging market owing to the increasing number of manufacturers coupled with the increasing market penetration.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Neuroendoscopy Market Global Analysis & Forecast to 2023 Research Report

Market Scenario:

Neuroendoscopy is characterized as a minimally-invasive surgical procedure which is extensively utilized to remove tumors. The excision occurs via small holes present in the skull, i.e., through the mouth or nose. In neuroendoscopy procedures, a small telescopic device equipped with a high-resolution video camera and an eyepiece is used. This gives the neurosurgeons, an ability to navigate and effectively access the parts of the brain that could not be addressed by traditional surgery. Some of the other advantages of neuroendoscopy include fast recovery, minimal scarring, and others.
The increasing prevalence of brain tumors is a major driver for the market growth. According to a study published by the Neuro-Oncology Journal in 2015, the global incidence rate for all types of brain tumors was estimated to be about 10.82 per 100 000 persons.
The increasing prevalence of brain tumors, increasing demand for minimally invasive surgical procedures, growing geriatric population, and favorable reimbursement policies are estimated to drive the global neuroendoscopy market, during the forecast period. However, a dearth of physicians and the high cost of neuroendoscopy procedures and equipment are projected to restrain the market growth during the forecast period.
Global Neuroendoscopy Market is expected to grow at an approximate CAGR of 5.2% during the forecast period.
According to the National Institute of Health in 2016, the global geriatric population is estimated to be more than triple from 2015 to 2050, i.e., it is projected to grow from 126.5 in 2015 million and reach 446.6 million by 2050. However, a shortage of physicians and high cost for neuroendoscopy procedures and equipment are projected to restrain the market growth during the forecast period. The Association of American Medical Colleges in 2016 stated that the demand for physicians continued to grow at a higher rate, exceeding the supply. The projected total physician shortfall by 2025 is estimated to be in between 61,700 and 94,700.
Key players
The key players in the global neuroendoscopy market are KARL STORZ (Germany), B. Braun (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hangzhou Hawk Optical Electronic Instruments (China), Machida Endoscope (Japan), Tonglu Wanhe Medical Instrument (China), Schindler Endoskopie (Germany), Clarus Medical (U.S.), LocaMed (U.K), Visionsense Corporation (U.S.), Olympus Corporation (Japan), Zeiss International (Germany), Stryker (U.S.), Medtronic (U.S.), and others.
Segmentation
The global Neuroendoscopy market is segmented on the basis of product, application, usability, and end-user.
On the basis of products, the market is segmented into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment is sub-segmented into rigid video scopes and rigid fiberscopes. On the basis of application, the market is categorized into transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuro-endoscopy. On the basis of usability, the market is segmented into reusable neuroendoscopes and disposable neuroendoscopes. On the basis of end-users, the market is segmented into hospitals, clinics, medical research centers, and others.
Regional Analysis
The Americas dominates the global neuroendoscopy market. Factors such as the increasing prevalence of brain tumors, the presence of a well-developed healthcare sector, and huge health care expenditures within the region drive the market growth within the region. Moreover, the presence of key players such as Stryker and Medtronic, besides others and the growing geriatric population within the region fuel the market growth.
Europe stands second in the global neuroendoscopy market due to the increasing demand for minimally invasive surgeries, rising availability of funds for research and development, and a huge patient population. According to the Cancer Research U.K., the total number of new cases for brain tumor was estimated to be about 11,432 in 2015.  
Followed by Europe, Asia Pacific stands third in the global neuroendoscopy market. Moreover, the region is projected to be the fastest growing region in the global market. This can be attributed to the presence of developing economies such as China, growing patient population, developing healthcare sector, and increasing per capita healthcare expenditures. Additionally, favorable government policies support the market growth. Medical tourism and rising geriatric population are estimated to fuel the market growth. According to the Indian Brand Equity Foundation, the medical tourism industry in India is estimated to grow rapidly and reach USD 9 billion by 2020.
The Middle East and Africa holds the least share in the global neuroendoscopy market due to the presence of poor economies, stringent government policies, lack of awareness, low per capita income, and poor availability of healthcare services, especially within the African region. A majority of the neuroendoscopy market within the region is held by the Middle East due to the presence of a well-developed healthcare sector and huge healthcare expenditure.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Picture Archiving and Communications Systems Market Analysis Revealing Key Drivers, Growth Trends and Competitive Assessment through 2023

Market Scenario:
Radiology imaging solutions have generated a significant return on its healthcare IT investment by implementing Exa’s Voice Recognition in place of traditional transcriptionists, and their productivity has increased by 400%.           
Picture Archiving and Communication System (PACS) is a modality of the medical imaging technology used specifically for image transmission from the site of image acquisition to other locations. The technology is convenient to access multiple modalities such as radiographs, CT scan, MRI, ultrasound, and others.
It is noted that the increasing prevalence of chronic diseases and the growing geriatric population are the key factors driving the PACS market. The increasing burden of chronic diseases has been observed in different parts of the world. Population in the low socio-economic group is mostly found to get affected by these chronic diseases. According to the report published in the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults are dealing with at least one type of cardiovascular disease. The prevalence of type-2 diabetes, obesity, and cardiovascular diseases has increased rapidly in the recent years, suggested by a study published in the BMC Public Health in 2017.
Various other factors such as supportive investments and funds provided by government and private bodies, rising demand for early diagnosis, technological advancements in the medical imaging devices, rising incidence of cancer, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, and increasing government assistance are continuously contributing to the growth of the global PACS market.
Despite these drivers, there are some issues associated with the PACS market. The high cost associated with the technology, lack of healthcare insurance, lack of awareness, and poor healthcare system in low- and middle-income countries may hamper the growth of the market.
It is estimated that the Picture Archiving and Communications Systems (PACS) market is expected to boost at a CAGR 7.0% during the forecast period of 2017–2023.
Key Players
Some of the key players in the global Picture Archiving and Communications Systems (PACS) market are Advanced Data Systems, Agfa-Gevaert N.V., Allscripts Healthcare Solutions, Inc., ALTA VISTA TELERADIOLOGY, Argus Radiology, Avreo, Inc., Brit Systems, Comarch SA, Cybernet Medical Corporation, FujiFilm Medical Systems, GE Healthcare, Global Diagnostics, INFINITT Healthcare, Konica Minolta Healthcare Americas Inc., McKesson Corporation,Inc., ONRAD, Inc., Pacshealth, LLC, PERFECT IMAGING, LLC, RamSoft, Inc., Radiology Imaging Solutions, Scimage, Inc., Sectra Imtec AB, Sectra Imtec AB, Siemens Healthineers, Singular Medical Technologies, StatRad, LLC, Telediagnostics Services Pvt. Ltd., Telerad Tech Private Limited, Virtual Radiology (vRAD), and others
Segmentation
The global Picture Archiving and Communications Systems (PACS) market is segmented on the basis of type, component, imaging type, delivery mode, and end-user.
On the basis of the type of imaging type, the market is classified as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), nuclear imaging, X-ray, and ultrasound.
On the basis of end-user, the market is classified as hospitals and clinics, healthcare centers, imaging centers, diagnostic centers, clinical research institutions, and others.
On the basis of delivery mode, the market is classified as cloud-based (SAAS) delivery mode, web-hosted (On-Demand) delivery mode, and on-premise mode.
On the basis of type, the market is classified as oncology PACS, cardiology PACS, dental PACS, orthopedics PACS, and others.
On the basis of components, the market is classified as hardware, software, and services. The hardware segment is further classified as access devices, peripherals, servers, storage devices, and networking devices. The services segment is further classified as consulting, implementation services, post-sales and maintenance services, and training services.
Regional Analysis
Asia Pacific is the fastest growing Picture Archiving and Communications Systems (PACS) market owing to a huge patient pool, increasing demand for diagnosis, and development in the healthcare IT sector. According to IBEF, the Healthcare Information Technology (IT) market was valued at USD 1 billion in 2016 which is estimated to grow 1.5 times by 2020.
The Americas dominates the Picture Archiving and Communications Systems (PACS) market owing to the rising demand for early diagnosis, rising prevalence of chronic diseases, well-developed technology, high healthcare expenditure, and the presence of leading players. Owing to the rising demand for imaging devices, various market players are coming up with advanced technology. For instance, on March 26, 2018, Singular Medical Technologies (SMT), the U.S. based technology company announced two new additions to its PACStation suite of products. The PACStation-GO is a fully functional reading workstation, with two full-size diagnostic monitors and is completely portable.
Europe holds the second position in the Picture Archiving and Communications Systems (PACS) market. It is expected that the funding towards research and development expenditure and increasing competition among marketers are likely to drive the European market.
The Middle East and Africa holds the lowest share of the global Picture Archiving and Communications Systems (PACS) market due to low development, lack of technical knowledge, and poor medical facilities.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Monday, 30 March 2020

Microspheres Market 2019 - Industry Growth, Analysis, Size and Share to 2023

Market Scenario:
The Global Microspheres Market is growing rapidly. The growth of the market is majorly influenced by the various applications and advancements of microspheres in controlled drug delivery system. Other factors that are influencing this market are increasing advancement in drug development, increasing user of microspheres for clinical research and others. Globally the market of microspheres is expected to grow at a CAGR of about 11.9% till 2022 and the growth at this rate has started since 2016.
Key Players for Microspheres Market:
Some of the key players in this market are: 3M (Unites States), Potters Industries LLC (United States), AkzoNobel N.V. (Netherlands), Momentive Performance Materials Inc. (United States), Chase Corporation (United States), Matsumoto Yushi Seiyaku Company (Japan), Mo-Sci Corporation (United States), Trelleborg AB (Sweden), Luminex Corporation (United States) and others.
Study Objectives of the Market:
Providing a detail analysis of the market structure along with forecast for the next 7 years related to various segments and sub-segments of the Microspheres market.
Giving insights about factors affecting the market growth.
Analyzing the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.
Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and various markets globally.
Giving regional level analysis of the market with respect to the current market size and future prospect.
Giving regional level analysis of the market with respect to segments, by material, by types, by application, also giving regional level analysis of the market’s sub-segments.
Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure.
Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments in the global Microspheres market.
Segments:
Global Microspheres market has been segmented on the basis of material which comprises synthetic polymers and natural polymers. On the basis of types the market is segmented into bioadhesive microspheres, magnetic microspheres, floating microspheres, radioactive microspheres, and polymeric microspheres. Furthermore on the basis of application the market is segmented into drug carriers, pulmonary drug delivery, tissue regeneration and others.
Intended Audience:
Pharmaceutical companies
Hospitals
Clinics
Academic research institutes
Government institutes
Regional Analysis of Microspheres Market:
North America is the largest market of global microspheres market. The North American market for microspheres is expected to grow at the CAGR of 11.3% from 2016 to 2022. Europe is the second largest market for Microspheres which is expected to grow at a CAGR of 11.5%. Asia Pacific region is expected to be fastest growing region of the global Microspheres market.

Visit For More Details @  https://www.marketresearchfuture.com/reports/microspheres-market-2268 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Biomarkers Market Comprehensive Overview, Industry Size, Booming Share, Key Players Review, Phenomenal Growth and Business Boosting Strategies till 2023

Biomarkers Market is projected to reach USD 40 Billion in 2018 and expected to register a 13.5% CAGR during the forecast period. Biomarkers are molecules that indicate normal or abnormal processes taking place in the human body and may be a sign of an underlying condition or disease. Various types of molecules, such as DNA, proteins, or hormones, can serve as biomarkers.
The primary factors driving the growth of global biomarkers market are increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, and high prevalence of cancer. According to The American Cancer Society, more than 1.7 million new cancer cases are expected to be diagnosed in 2019 in the Americas. According to the World Health Organization (WHO), more than 3.7 million new cases and 1.9 million deaths occur each year in Europe, and cancer represents the second most important cause of death and morbidity in Europe.
However, high capital investments and technical issues related to sample collection and storage are expected to restrain the growth of the market.
Segmentation
The Global Biomarkers Market has been segmented into Product, Type, Application, and Disease Indication.
By product, the market has been segmented into consumables, services, and software.
On the basis of type, the market has been segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. Efficacy biomarkers are further sub-segmented into predictive biomarkers, surrogate biomarkers, pharmacodynamic biomarkers, and prognostic biomarkers.
Based on application, the market has been segmented into diagnostics, drug discovery and development, personalized medicine, disease risk assessment, and other applications.
Based on disease indication, the market has been segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biomarkers market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European Biomarkers market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Biomarkers market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The Biomarkers market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Qiagen N.V. (Germany), Perkinelmer, Inc. (US), Merck Millipore (US), Bio-Rad Laboratories, Inc. (US), Enzo Biochem, Inc. (US), EKF Diagnostics Holdings, Inc. (UK), Meso Scale Diagnostics, LLC (US), Biosims Technologies Sas (France), Cisbio Bioassays (France), and Signosis, Inc. (US) are some of the Key Players in the Global Biomarkers Market.

Visit For More Details @ https://www.marketresearchfuture.com/reports/biomarker-market-1941 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Digital pathology Market 2019 - Industry Growth, Analysis, Size and Share to 2023

Digital Pathology comprises an array of equipment capable of capturing, analyzing, interpreting, and managing digital information gained from slides. The technology is gaining focus rapidly thanks to its wide application in tissue-based research, human pathology, and drug development. Global Digital Pathology Market is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023 and expected to reach USD 8,305.6 MN by 2023.
The rise in the number of pathologists, benefits of digital pathology, and its rapid use in the healthcare sector are factors anticipated to drive market demand during the forecast period. Adoption of electronic health records (EHRs), integration of automation to expedite workflow, and technological improvements in image analysis software are other factors likely to influence the buying decisions of hospitals and clinics. But high implementation costs of digital pathology combined with stringent regulatory policies can act as roadblocks for the market.
Digital Pathology Market Report Overview
The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts make highly astute projections regarding the scope of the market and its future prospects. MRFR’s report includes a thorough analysis of the global digital pathology market segmented by type, product, application, end-user, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.

Digital Pathology Market Segment 

Types of digital pathology include human and animal pathology. Products in the digital pathology market includes software, hardware, and storage. Major applications include disease diagnosis, drug discovery, Mhealth, and telemedicine. In terms of end-users, the market is segmented into hospitals & clinics, research centers & academic institutes, and diagnostic centers.
The digital pathology market segments covered in the report are analyzed with respect to four major regions – The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA), with respective country-level market sizing. The definition and advantages of “digital pathology” are outlined in the report for a comprehensive understanding of the market. The report discusses in minute detail the various players and the strategies outlined by them to enhance their value chain.
Digital Pathology Market Competitive Landscape
Noteworthy participants in the digital pathology market include Olympus Corporation (Japan), Danaher Corporation (Leica Biosystems GmbH) (U.S.), Inspirata (U.S.), 3DHISTECH Ltd. (Hungary), Huron Digital Pathology Inc. (Canada), Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), microdimensions GmbH (Germany), Definiens (Germany), Mikroscan Technologies, Inc. (U.S.), among others.
The report offers comprehensive profiles on these digital pathology market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, expansion techniques, and latest R&D initiatives is discussed in minute detail.

Visit For More Details @   https://www.marketresearchfuture.com/reports/digital-pathology-market-1955 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Apheresis Market Growth Trends, Size Estimation, Industry Analysis, Sales Statistics, Global Share, Leading Key Players and Regional Forecast 2023

Apheresis is the medical technology which is used for the purification of the blood or separation of different component of blood. It involves removing of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is send back to the donor or patients. This separation of the component was done by two process namely centrifugation and filtration. Global apheresis market is driven by development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases and many more. Increasing demand for the different component of the bloods, rising complex surgical procedures and increasing number of accidents across the globe has also contributed in the growth of the market. According to National Health Service (NHS) Blood and Transplant, the demand for platelets. While lack of skilled professional and Blood and blood product can be infected very easily, this risk of infection also contribute in hindering the market growth.
The market for apheresis is increasing at a rapid pace which is expected to grow at a CAGR of 10.2% during forecasted period 2017-2023.
Segmentation:
Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures, they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application, the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.
Study Objectives Global Apheresis Market:
Detail analysis of global apheresis market with region specific growth and competitive analysis on the basis of major players present in the market
Detail analysis of global apheresis market and different drivers and restraints affecting the growth of the market
Detailed analysis of the historical and forecasted market analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global apheresis
Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- Americas, Europe, Asia Pacific and Middle East and Africa.
Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future
Intended Audience
  • Apheresis manufacturers
  • Apheresis suppliers
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities
Regional analysis:
On regional basis, Americas hold the largest share in the global apheresis market. Continuous advance in technology, increasing opportunity for apheresis products and presence of a huge number of people suffering from different chronic diseases has spurred the growth of this market in Americas. Europe is the second leading market which is followed by Asia Pacific. However Asia Pacific is the fastest growing region for the market. Increasing demand for different blood components for the patients, rapid development in healthcare and increasing healthcare expenditure are contributing in the growth of Asia Pacific apheresis market.
Key Players For Global Apheresis Market:
Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).

Visit For More Details @  https://www.marketresearchfuture.com/reports/apheresis-market-1508 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Subscribe to: Posts (Atom)